3Sbio
3Sbio is a Chinese biopharmaceutical company known for its focus on the development of innovative therapies, particularly in the field of oncology. Recently, the company has been in the news due to a significant licensing agreement with Pfizer, which includes a $6 billion deal to develop and commercialize a promising bispecific antibody called SSGJ-707, aimed at treating various types of cancer, including non-small cell lung cancer and metastatic colorectal cancer.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
3Sbio is a biopharmaceutical company in China that signed a licensing agreement with Pfizer.
7